Geneoscopy Honored by Goldman Sachs for Entrepreneurship
Retrieved on:
Wednesday, October 13, 2021
GS, Goldman Sachs, View, MBA, Diagnosis, Entrepreneurship, Jane Barnell, World Innovation Summit for Health, Economics, Lindsay Goldberg, Charles H. Dyson School of Applied Economics and Management, BA, Builder, J.P. Morgan & Co., Disease, NYSE, Specialization, Multimedia, RNA, Serna, Colorectal cancer, Company, Wharton School of the University of Pennsylvania, J. P. Morgan, CEO, Innovation, US, Cornell University, Management
Goldman Sachs selected Barnell as one of 100 entrepreneurs from multiple industries to be honored at the two-day event.
Key Points:
- Goldman Sachs selected Barnell as one of 100 entrepreneurs from multiple industries to be honored at the two-day event.
- Prior to co-founding Geneoscopy, he was an associate at Lindsay Goldberg, a middle-market private equity firm focused on partnering with family-owned businesses.
- "We are honored to have Andrew recognized as part of this distinguished group of entrepreneurs," commented Vince Wong, Geneoscopy's Chief Commercial Officer.
- "Innovation doesn't happen just anywhere; it thrives where there's a wide range of thoughts and perspectives," said David M. Solomon, Chairman & CEO of Goldman Sachs.